Influence of tacrolimus and prednisone on serum lipids after liver transplantation

Journal of Parenteral and Enteral Nutrition

Volumn 25, Issue 3, 2001, Pages 148-151

  Scolapio, J S ^a   Bowen, J ^a   Lukens, F J ^a   Ukleja, A ^a   Atkinson, E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; TACROLIMUS; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; LIPID BLOOD LEVEL; LIVER TRANSPLANTATION; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS; STATISTICAL ANALYSIS; VIRUS HEPATITIS;

EID: 0035035645     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607101025003148     Document Type: Article

References (17)

1. Hyperlipidemia and obesity after orthotopic liver transplantation
2. Serum lipid abnormalities in pediatric liver transplant recipients
3. Hyperlipidemia and other coronary risk factors after orthotopic liver transplantation: Pathogenesis, diagnosis and management
4. Lipoprotein and hepatic lipase activity and high-density lipoprotein subclasses after cardiac transplantation
5. Cardiovascular disease after renal transplantation
6. Cyclosporin, low density lipoprotein, and cholesterol
7. Evolution of cardiovascular risk after liver transplantation: A comparison of cyclosporine A and tacrolimus (FK506)
8. Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation
9. Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK506 in liver transplantation
10. Influence of long-term cyclosporine or FK506 therapy on glucose and lipid metabolism in stable liver graft recipients
11. Lipoprotein abnormalities in long term stable liver and renal transplanted patients. A comparative study
12. Hyperlipidemia in liver transplant recipients: Prevalence and risk factors
13. Cholesterol levels long term after liver transplant
14. Hyperlipidemia after liver transplantation
15. Serum lipids and apolipoproteins in liver transplant recipients: A comparative study of cyclosporin A and FK 506
16. Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK 506
17. Hyperlipidemia after liver transplantation: Long term results of the FK 506/cyclosporine a US multicenter trial